Patents-Review.com
ClassID:

109793 ⎘

C12N2710/16151 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae; Cytomegalovirus, e.g. human herpesvirus 5 Methods of production or purification of viral material

Sub-classes:
Recent Application in this class:
#1
20250082748
2025-03-13

HUMAN CYTOMEGALOVIRUS RNA VACCINES

 #2
20240150789
2024-05-09

Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis

 #3
20230293675
2023-09-21

GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF

 #4
20220324947
2022-10-13

Identification and Elimination of HCMV-Infected Cells

 #5
20220177921
2022-06-09

GENE THERAPY USING GENETICALLY MODIFIED VIRAL VECTORS

 #6
20220106364
2022-04-07

COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

 #7
20210403951
2021-12-30

Recombinant cytomegalovirus vectors as vaccines for tuberculosis

 #8
20210380952
2021-12-09

Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate

 #9
20200316193
2020-10-08

Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and methods of preparation thereof

 #10
20200246453
2020-08-06

Human cytomegalovirus RNA vaccines

 #11
20190321464
2019-10-24

Human cytomegalovirus RNA vaccines

 #12
20190218524
2019-07-18

Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate

 #13
20180346885
2018-12-06

Method to increase the infectivity of virus particles

 #14
20180298348
2018-10-18

Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate

 #15
20180271975
2018-09-27

Human cytomegalovirus RNA vaccines

 #16
20180030417
2018-02-01

METHOD OF ALTERING EXPRESSION OF ALTERNATIVE VIRAL GLYCOPROTEIN COMPLEXES

 #17
20180028645
2018-02-01

Human cytomegalovirus RNA vaccines

 #18
20180016599
2018-01-18

Recombinant cytomegalovirus vectors as vaccines for tuberculosis

 #19
20170369532
2017-12-28

Cytomegalovirus antigens and uses thereof

 #20
20170362278
2017-12-21

Mammalian cells expressing cytomegalovirus antigens

 #21
20170320916
2017-11-09

Complexes of cytomegalovirus proteins

 #22
20170246292
2017-08-31

Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof

 #23
20170119874
2017-05-04

HUMAN CYTOMEGALOVIRUS VACCINE COMPOSITIONS AND METHOD OF PRODUCING THE SAME

 #24
20170014504
2017-01-19

Cytomegalovirus vaccines and methods of production

 #25
20160243216
2016-08-25

CMV IMMUNO-STIMULATORY COMPOSITION

 #26
20160159864
2016-06-09

Complexes of cytomegalovirus proteins

 #27
20160130565
2016-05-12

Method to Produce Virus in Cultured Cells

 #28
20150322115
2015-11-12

MEANS AND METHODS FOR TREATING CMV

 #29
20140212950
2014-07-31

Method to increase the infectivity of virus particles

 #30
20140178432
2014-06-26

Production of dense bodies (DB) from HCMV-infected cells

 #31
20140113353
2014-04-24

Method to produce virus in cultured cells

 #32
20100316667
2010-12-16

Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof

 #33
20100285059
2010-11-11

Cytomegalovirus vaccines and methods of production

 #34
20070065939
2007-03-22

Systems for detection and production of respiratory, herpes and enteric viruses